Obesity, Type 2 Diabetes, Insulin Sensitivity
Conditions
Keywords
Obesity, Bariatric Surgery, Insulin Sensitivity
Brief summary
Obese patients have an increased risk for developing severe metabolic disorders. This risk can only partly be reduced by weight reduction. The investigators have in a pilot study investigated if removal of abdominal fat (visceral) in addition to weight loss has additional beneficial effects on the metabolic profile and weight loss. This study aims to further investigate if removal of abdominal fat (major omentum) leads to beneficial metabolic effects.
Interventions
Sponsors
Study design
Eligibility
Inclusion criteria
Body mass index over 40 kg/m2 Body mass index over 35 kg/m2 with obesity associated co-morbidities such as type 2 diabetes and/or additional cardiovascular risk factors -
Exclusion criteria
\-
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Insulin Sensitivity at 2 Years | 2 years postoperative | Insulin sensitivity measured by hyperinsulinemic euglycemic clamp |
Secondary
| Measure | Time frame |
|---|---|
| Body Composition at Two Years | 2 years postoperative |
| Blood Pressure at 2 Years | 2 years postoperative |
| Body Mass Index at 2 Years | 2 years postoperative |
| Blood Lipids | 2 years postoperative |
Countries
Sweden
Participant flow
Participants by arm
| Arm | Count |
|---|---|
| Control Gastric bypass operation without omentectomy.
Gastric bypass operation | 41 |
| Omentectomy Gastric bypass operation in conjunction with removal of greater omentum
Omentectomy
Gastric bypass operation | 40 |
| Total | 81 |
Baseline characteristics
| Characteristic | Control | Omentectomy | Total |
|---|---|---|---|
| Age, Continuous | 41 years STANDARD_DEVIATION 9 | 43 years STANDARD_DEVIATION 9 | 42 years STANDARD_DEVIATION 9 |
| Region of Enrollment Sweden | 41 participants | 40 participants | 81 participants |
| Sex: Female, Male Female | 41 Participants | 40 Participants | 81 Participants |
| Sex: Female, Male Male | 0 Participants | 0 Participants | 0 Participants |
Adverse events
| Event type | EG000 affected / at risk | EG001 affected / at risk |
|---|---|---|
| deaths Total, all-cause mortality | — / — | — / — |
| other Total, other adverse events | 0 / 41 | 0 / 40 |
| serious Total, serious adverse events | 0 / 41 | 0 / 40 |
Outcome results
Insulin Sensitivity at 2 Years
Insulin sensitivity measured by hyperinsulinemic euglycemic clamp
Time frame: 2 years postoperative
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| Control | Insulin Sensitivity at 2 Years | 6.7 glucose/kg body weight/min | Standard Deviation 1.6 |
| Omentectomy | Insulin Sensitivity at 2 Years | 6.6 glucose/kg body weight/min | Standard Deviation 1.5 |
Blood Lipids
Time frame: 2 years postoperative
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| Control | Blood Lipids | 4.0 P-Cholesterol mmol/L | Standard Deviation 0.9 |
| Omentectomy | Blood Lipids | 4.2 P-Cholesterol mmol/L | Standard Deviation 0.8 |
Blood Pressure at 2 Years
Time frame: 2 years postoperative
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| Control | Blood Pressure at 2 Years | 123 mm Hg systolic | Standard Deviation 16 |
| Omentectomy | Blood Pressure at 2 Years | 121 mm Hg systolic | Standard Deviation 23 |
Body Composition at Two Years
Time frame: 2 years postoperative
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| Control | Body Composition at Two Years | 36 % body fat | Standard Deviation 8 |
| Omentectomy | Body Composition at Two Years | 38 % body fat | Standard Deviation 8 |
Body Mass Index at 2 Years
Time frame: 2 years postoperative
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| Control | Body Mass Index at 2 Years | 28.6 Kg/meter squared | Standard Deviation 4.6 |
| Omentectomy | Body Mass Index at 2 Years | 28.9 Kg/meter squared | Standard Deviation 4.3 |